DK0703981T3 - Immunogene sammensætninger mod Helicobacterinfektion, polypeptider til anvendelse i sammensætningerne og nucleinsyresekvenser, som koder for nævnte polypeptider - Google Patents
Immunogene sammensætninger mod Helicobacterinfektion, polypeptider til anvendelse i sammensætningerne og nucleinsyresekvenser, som koder for nævnte polypeptiderInfo
- Publication number
- DK0703981T3 DK0703981T3 DK94917653T DK94917653T DK0703981T3 DK 0703981 T3 DK0703981 T3 DK 0703981T3 DK 94917653 T DK94917653 T DK 94917653T DK 94917653 T DK94917653 T DK 94917653T DK 0703981 T3 DK0703981 T3 DK 0703981T3
- Authority
- DK
- Denmark
- Prior art keywords
- polypeptides
- fragment
- compositions
- helicobacter
- nucleic acid
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 230000002163 immunogen Effects 0.000 title abstract 3
- 206010019375 Helicobacter infections Diseases 0.000 title abstract 2
- 150000007523 nucleic acids Chemical group 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 5
- 108010046334 Urease Proteins 0.000 abstract 4
- 241000590017 Helicobacter felis Species 0.000 abstract 2
- 241000590002 Helicobacter pylori Species 0.000 abstract 2
- 229940037467 helicobacter pylori Drugs 0.000 abstract 2
- 108050001186 Chaperonin Cpn60 Proteins 0.000 abstract 1
- 102000052603 Chaperonins Human genes 0.000 abstract 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 abstract 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 abstract 1
- 241000589989 Helicobacter Species 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/24—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93401309 | 1993-05-19 | ||
| PCT/EP1993/003259 WO1995014093A1 (en) | 1993-05-19 | 1993-11-19 | Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
| PCT/EP1994/001625 WO1994026901A1 (en) | 1993-05-19 | 1994-05-19 | Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0703981T3 true DK0703981T3 (da) | 2007-10-08 |
Family
ID=26070083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94917653T DK0703981T3 (da) | 1993-05-19 | 1994-05-19 | Immunogene sammensætninger mod Helicobacterinfektion, polypeptider til anvendelse i sammensætningerne og nucleinsyresekvenser, som koder for nævnte polypeptider |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6248330B1 (da) |
| EP (1) | EP0703981B1 (da) |
| JP (4) | JPH08509873A (da) |
| AT (1) | ATE364083T1 (da) |
| AU (1) | AU689779B2 (da) |
| CA (1) | CA2144307C (da) |
| DE (1) | DE69434985T2 (da) |
| DK (1) | DK0703981T3 (da) |
| ES (1) | ES2288753T3 (da) |
| SG (1) | SG52480A1 (da) |
| WO (2) | WO1995014093A1 (da) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995014093A1 (en) | 1993-05-19 | 1995-05-26 | Institut Pasteur | Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
| US5874405A (en) * | 1994-12-16 | 1999-02-23 | Birnbaum; Gary | Heat shock protein peptides that share sequences with cyclic nucleotide phosphodiesterase and methods for modulating autoimmune central nervous system disease |
| JP4368944B2 (ja) * | 1995-04-21 | 2009-11-18 | シーエスエル、リミテッド | 防御用ヘリコバクター抗原 |
| DE69637947D1 (de) * | 1995-04-28 | 2009-07-23 | Merieux Oravax Snc | Multimerer, rekombinanter urease impfstoff |
| WO1996034624A1 (en) * | 1995-05-02 | 1996-11-07 | Institut Pasteur | Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides |
| US7022328B1 (en) | 1995-11-30 | 2006-04-04 | Australian Pork Limited | Therapeutic and diagnostic compositions |
| GB2307987A (en) * | 1995-12-06 | 1997-06-11 | Univ Manchester | Epitopes of the urease of Helicobacter pylori as dignostic agents; pharmaceuticals comprising such epitopes or the antibodies thereto |
| WO1997025429A1 (en) * | 1996-01-04 | 1997-07-17 | Rican Limited | Helicobacter pylori bacterioferritin |
| DE19630390A1 (de) * | 1996-07-26 | 1998-01-29 | Chiron Behring Gmbh & Co | Proteine, insbesondere Membranproteine von Helicobacter pylori, ihre Herstellung und Verwendung |
| EP0835928A1 (en) * | 1996-10-11 | 1998-04-15 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin | Helicobacter pylori live vaccine |
| US6248551B1 (en) * | 1997-03-28 | 2001-06-19 | Institut Pasteur | Helicobacter aliphatic amidase AmiE polypeptides, and DNA sequences encoding those polypeptides |
| JP3430853B2 (ja) * | 1997-04-11 | 2003-07-28 | 株式会社ゲン・コーポレーション | 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤 |
| AU7537598A (en) * | 1997-04-30 | 1998-11-24 | Pasteur Merieux Serums Et Vaccins | Dna based anti-(helicobacter) vaccine composition |
| US5985631A (en) * | 1997-09-12 | 1999-11-16 | Oravax-Merieux Co. | Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease |
| US20020151462A1 (en) * | 1998-02-19 | 2002-10-17 | Ling Lissolo | Helicobacter pylori membrane proteins |
| US6190667B1 (en) | 1998-06-30 | 2001-02-20 | Institut Pasteur | Methods of inhibiting Helicobacter pylori |
| CA2351110A1 (en) * | 2000-07-17 | 2002-01-17 | Akzo Nobel N.V. | Helicobacter felis vaccine |
| GB0021757D0 (en) * | 2000-09-04 | 2000-10-18 | Colaco Camilo | Vaccine against microbial pathogens |
| US7264800B2 (en) * | 2002-07-18 | 2007-09-04 | Helix Biopharma Corporation | Method and composition for inhibiting cancer cell growth |
| AU2003250658B2 (en) * | 2002-07-18 | 2009-07-16 | Helix Biopharma Corp. | Use of urease for inhibiting cancer cell growth |
| US7790143B2 (en) | 2005-06-16 | 2010-09-07 | Universiteit Gent | Vaccines for immunization against helicobacter |
| CA2612271A1 (en) * | 2005-06-16 | 2006-12-21 | Universiteit Gent | Vaccines for immunization against helicobacter |
| RU2689689C2 (ru) | 2015-01-23 | 2019-05-28 | Хеликс Байофарма Корпорейшн | Конъюгаты антитело-уреаза для терапевтических целей |
| WO2023118394A1 (en) * | 2021-12-23 | 2023-06-29 | Intervet International B.V. | Dna vaccine against leishmaniasis |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5459041A (en) * | 1988-02-18 | 1995-10-17 | Enteric Research Laboratories, Inc. | Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection |
| FR2637612B1 (fr) * | 1988-10-06 | 1993-09-10 | Pasteur Institut | Sequences de nucleotides codant pour une proteine a activite ureasique |
| GB8928625D0 (en) * | 1989-12-19 | 1990-02-21 | 3I Res Expl Ltd | H.pylori dna probes |
| US5262156A (en) * | 1991-08-12 | 1993-11-16 | Hycor Biomedical, Inc. | Antigenic compositions and their use for the detection of Helicobacter pylori |
| FR2682122B1 (fr) * | 1991-10-03 | 1995-06-09 | Pasteur Institut | Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori. |
| WO1993016723A1 (en) | 1992-02-26 | 1993-09-02 | Vanderbilt University | Purified vacuolating toxin from helicobacter pylori and methods to use same |
| EP0967279B1 (en) * | 1992-03-02 | 2008-01-02 | Novartis Vaccines and Diagnostics S.r.l. | Helicobacter pylori cytotoxin useful for vaccines and diagnostics |
| MX9301706A (es) | 1992-04-13 | 1994-05-31 | Oravax Inc | Composicion de vacuna para el tratamiento de la infeccion por helicobacter. |
| PT661990E (pt) * | 1992-08-26 | 2002-09-30 | Celtrix Pharma | Metodo para tratamento sistemico de condicoes catabolicas e de lesoes sistemicas em tecidos |
| WO1994006474A1 (en) * | 1992-09-16 | 1994-03-31 | Galagen Inc. | ANTIBODY TREATMENT OF $i(HELICOBACTER PYLORI) |
| US5972336A (en) | 1992-11-03 | 1999-10-26 | Oravax Merieux Co. | Urease-based vaccine against helicobacter infection |
| WO1995014093A1 (en) | 1993-05-19 | 1995-05-26 | Institut Pasteur | Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
| NZ269124A (en) | 1993-07-27 | 1997-06-24 | Csl Ltd | Vaccine comprising helicobacter antigens and its use in treating such infections |
| AR003125A1 (es) | 1995-06-01 | 1998-07-08 | Astra Ab | Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la |
| SK165197A3 (en) | 1995-06-07 | 1999-01-11 | Astra Ab | Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics |
-
1993
- 1993-11-19 WO PCT/EP1993/003259 patent/WO1995014093A1/en unknown
- 1993-11-19 JP JP7514170A patent/JPH08509873A/ja active Pending
-
1994
- 1994-05-19 DE DE69434985T patent/DE69434985T2/de not_active Expired - Fee Related
- 1994-05-19 AT AT94917653T patent/ATE364083T1/de not_active IP Right Cessation
- 1994-05-19 WO PCT/EP1994/001625 patent/WO1994026901A1/en active IP Right Grant
- 1994-05-19 AU AU69290/94A patent/AU689779B2/en not_active Ceased
- 1994-05-19 ES ES94917653T patent/ES2288753T3/es not_active Expired - Lifetime
- 1994-05-19 SG SG1996005085A patent/SG52480A1/en unknown
- 1994-05-19 JP JP52499794A patent/JP3955317B2/ja not_active Expired - Fee Related
- 1994-05-19 DK DK94917653T patent/DK0703981T3/da active
- 1994-05-19 CA CA002144307A patent/CA2144307C/en not_active Expired - Fee Related
- 1994-05-19 EP EP94917653A patent/EP0703981B1/en not_active Expired - Lifetime
-
1995
- 1995-05-02 US US08/432,697 patent/US6248330B1/en not_active Expired - Fee Related
-
2004
- 2004-06-02 JP JP2004164306A patent/JP2004337170A/ja active Pending
-
2007
- 2007-09-27 JP JP2007252748A patent/JP2008086316A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ATE364083T1 (de) | 2007-06-15 |
| AU689779B2 (en) | 1998-04-09 |
| US6248330B1 (en) | 2001-06-19 |
| AU6929094A (en) | 1994-12-12 |
| JP3955317B2 (ja) | 2007-08-08 |
| JP2004337170A (ja) | 2004-12-02 |
| EP0703981B1 (en) | 2007-06-06 |
| JPH08510120A (ja) | 1996-10-29 |
| JPH08509873A (ja) | 1996-10-22 |
| WO1995014093A1 (en) | 1995-05-26 |
| DE69434985T2 (de) | 2008-02-21 |
| WO1994026901A1 (en) | 1994-11-24 |
| CA2144307C (en) | 2008-09-02 |
| CA2144307A1 (en) | 1994-11-24 |
| ES2288753T3 (es) | 2008-01-16 |
| DE69434985D1 (de) | 2007-07-19 |
| EP0703981A1 (en) | 1996-04-03 |
| JP2008086316A (ja) | 2008-04-17 |
| SG52480A1 (en) | 1998-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0703981T3 (da) | Immunogene sammensætninger mod Helicobacterinfektion, polypeptider til anvendelse i sammensætningerne og nucleinsyresekvenser, som koder for nævnte polypeptider | |
| IL264925A (en) | Isolated or recombinant proteins that induce an immune response against S. PYOGENES, preparations containing them and their uses | |
| EA199800973A1 (ru) | Полипептид белка-106 наружной мембраны moraxella catarrhalis, последовательность гена и их применение | |
| DK0851927T3 (da) | Forbindelser til immunterapi og diagnosticering af tuberkulose | |
| CA2131729A1 (en) | Helicobacter pylori proteins useful for vaccines and diagnostics | |
| DK1489097T3 (da) | Hæmmere af humant plasmin, der er afledt af kunitz-domæner, og nukleinsyrer, der koder for samme | |
| EP1092774A3 (en) | Borrelia burgdorferi antigen OspA, gene encoding it and uses thereof | |
| NO329875B1 (no) | Isolert DNA-sekvens som koder for svinereproduktive- og respiratoriske syndromvirus (PRRSV), en sammensetning omfattende polypeptidene kodet av denne, en sammensetning for indusering av antistoffer mot PRRSV, anvendelse av sammensetning for fremstilling av vaksine og fremgangsmate for a skille PRRSV-stamme ISU-55 fra andre PRRSV-stammer. | |
| DK0770679T4 (da) | HCV-specifikke peptider, sammensætninger dertil og anvendelse deraf | |
| MY119003A (en) | Bacterial antigens and vaccine compositions | |
| WO2000012535A3 (en) | Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof | |
| NO991995L (no) | Nukleinsyre- og aminosyresekvenser relatert til Heliobacter pylori og vaksinesammensetninger derav | |
| NZ335633A (en) | Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases | |
| DK312787D0 (da) | Polypeptider, fremgangsmaade til deres fremstilling, dna som koder for polypeptiderne, vektorer indeholdende saadanne gensekvenser og laegemidler indeholdende polypeptiderne | |
| AU4469889A (en) | Interferon-gamma binding proteins | |
| NO20011263D0 (no) | Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav | |
| CA2235471A1 (en) | Dna encoding a plasminogen activating protein | |
| GR3003754T3 (da) | ||
| SE8800981A (sv) | A recombinant fusion protein, its use and a recombinant vector | |
| DK0386733T3 (da) | cDNA, som koder for placentaprotein 9 (PP9), dets isolering og anvendelse | |
| NZ311874A (en) | Recombinant and/or pure preparations of H. pylori polypeptides and nucleic acids which are useful for diagnostics and vaccines | |
| HU214696B (hu) | Eljárás libák és barbari kacsák parvovírusos megbetegedése elleni rekombináns vakcina és immunvizsgálati készlet előállítására | |
| TH38358A (th) | ลำดับกรดนิวคลีอิคและกรดอะมิโนที่เกี่ยวข้องกับHelicobacter pylori สำหรับการวินิจฉัยและรักษา | |
| TH43863A (th) | แอนติเจนแบคทีเรียและส่วนประกอบวัคซีน |